162 related articles for article (PubMed ID: 34845414)
1. LDH and GGT/ALT Ratio as Novel Prognostic Biomarkers in Hepatocellular Carcinoma Patients after Liver Transplantation.
Zhang Q; Jiao X
Comput Math Methods Med; 2021; 2021():9809990. PubMed ID: 34845414
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of alkaline phosphatase, gamma-glutamyl transpeptidase and lactate dehydrogenase in hepatocellular carcinoma patients treated with liver resection.
Wu SJ; Lin YX; Ye H; Xiong XZ; Li FY; Cheng NS
Int J Surg; 2016 Dec; 36(Pt A):143-151. PubMed ID: 27793641
[TBL] [Abstract][Full Text] [Related]
3. Elevated Preoperative Serum Gamma-glutamyltranspeptidase Predicts Poor Prognosis for Hepatocellular Carcinoma after Liver Transplantation.
Fu SJ; Zhao Q; Ji F; Chen MG; Wu LW; Ren QQ; Guo ZY; He XS
Sci Rep; 2016 Jul; 6():28835. PubMed ID: 27381639
[TBL] [Abstract][Full Text] [Related]
4. Preoperative serum gamma-glutamyl transferase to alanine aminotransferase ratio is a convenient prognostic marker for Child-Pugh A hepatocellular carcinoma after operation.
Ju MJ; Qiu SJ; Fan J; Zhou J; Gao Q; Cai MY; Li YW; Tang ZY
J Gastroenterol; 2009; 44(6):635-42. PubMed ID: 19387533
[TBL] [Abstract][Full Text] [Related]
5. The prognostic significance of serum gamma-glutamyltransferase levels and AST/ALT in primary hepatic carcinoma.
Zhang LX; Lv Y; Xu AM; Wang HZ
BMC Cancer; 2019 Aug; 19(1):841. PubMed ID: 31455253
[TBL] [Abstract][Full Text] [Related]
6. Infiltrative Hepatocellular Carcinoma: Assessment of Factors Associated With Outcomes in Patients Undergoing Hepatectomy.
Yan X; Fu X; Deng M; Chen J; He J; Shi J; Qiu Y
Medicine (Baltimore); 2016 May; 95(19):e3589. PubMed ID: 27175659
[TBL] [Abstract][Full Text] [Related]
7. Novel Value of Preoperative Gamma-Glutamyltransferase Levels in the Prognosis of AFP-Negative Hepatocellular Carcinoma.
Lu LH; Wei-Wei ; Kan A; Jie-Mei ; Ling YH; Li SH; Guo RP
Dis Markers; 2020; 2020():4269460. PubMed ID: 32695241
[TBL] [Abstract][Full Text] [Related]
8. Homocysteine: A novel prognostic biomarker in liver transplantation for alpha-fetoprotein- negative hepatocellular carcinoma.
Yang M; Tan W; Yang X; Zhuo J; Lin Z; Cen B; Lian Z; Li H; Lu D; Wei X; Zheng S; Xu X
Cancer Biomark; 2020; 29(2):197-206. PubMed ID: 32623388
[TBL] [Abstract][Full Text] [Related]
9. AGLR is a novel index for the prognosis of hepatocellular carcinoma patients: a retrospective study.
Liao Y; Wei R; Yao R; Qin L; Li J; Yu J; Liao W
BMC Surg; 2021 Feb; 21(1):72. PubMed ID: 33536005
[TBL] [Abstract][Full Text] [Related]
10. A new plasma biomarker enhance the clinical prediction of postoperative acute kidney injury in patients with hepatocellular carcinoma.
Zhou X; Wang L; Wang G; Cheng X; Hu S; Ke W; Li M; Zhang Y; Song Z; Zheng Q
Clin Chim Acta; 2017 Dec; 475():128-136. PubMed ID: 29031454
[TBL] [Abstract][Full Text] [Related]
11. Serum levels of preoperative α-fetoprotein and CA19-9 predict survival of hepatic carcinoma patients after liver transplantation.
Wan P; Zhang J; Long X; Li Q; Xu N; Zhang M; Chen X; Han L; Xia Q
Eur J Gastroenterol Hepatol; 2014 May; 26(5):553-61. PubMed ID: 24589829
[TBL] [Abstract][Full Text] [Related]
12. Preoperative serum liver enzyme markers for predicting early recurrence after curative resection of hepatocellular carcinoma.
Wang ZX; Jiang CP; Cao Y; Zhang G; Chen WB; Ding YT
Hepatobiliary Pancreat Dis Int; 2015 Apr; 14(2):178-85. PubMed ID: 25865691
[TBL] [Abstract][Full Text] [Related]
13. Model based on γ-glutamyltransferase and alkaline phosphatase for hepatocellular carcinoma prognosis.
Xu XS; Wan Y; Song SD; Chen W; Miao RC; Zhou YY; Zhang LQ; Qu K; Liu SN; Zhang YL; Dong YF; Liu C
World J Gastroenterol; 2014 Aug; 20(31):10944-52. PubMed ID: 25152598
[TBL] [Abstract][Full Text] [Related]
14. Expansion of the Milan criteria without any sacrifice: combination of the Hangzhou criteria with the pre-transplant platelet-to-lymphocyte ratio.
Xia W; Ke Q; Guo H; Wang W; Zhang M; Shen Y; Wu J; Xu X; Yan S; Yu J; Zhang M; Zheng S
BMC Cancer; 2017 Jan; 17(1):14. PubMed ID: 28056901
[TBL] [Abstract][Full Text] [Related]
15. Gamma glutamyl transpeptidase as a prognostic biomarker in hepatocellular cancer patients especially with >5 cm tumors, treated by liver transplantation.
Ince V; Carr BI; Bag HG; Koc C; Usta S; Ersan V; Baskiran A; Sahin TT; Yilmaz S
Int J Biol Markers; 2020 Jun; 35(2):91-95. PubMed ID: 32436751
[TBL] [Abstract][Full Text] [Related]
16. Alpha-fetoprotein level > 1000 ng/mL as an exclusion criterion for liver transplantation in patients with hepatocellular carcinoma meeting the Milan criteria.
Hameed B; Mehta N; Sapisochin G; Roberts JP; Yao FY
Liver Transpl; 2014 Aug; 20(8):945-51. PubMed ID: 24797281
[TBL] [Abstract][Full Text] [Related]
17. Elevation of serum GGT and LDH levels, together with higher BCLC staging are associated with poor overall survival from hepatocellular carcinoma: a retrospective analysis.
Yang Z; Ye P; Xu Q; Lu Y; Tang B; Wang Q; Chen S; Chen X
Discov Med; 2015 Jun; 19(107):409-18. PubMed ID: 26175398
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of γ-glutamyl transpeptidase to albumin ratio combined with aspartate aminotransferase to lymphocyte ratio in patients with hepatocellular carcinoma after hepatectomy.
Liu KJ; Lv YX; Niu YM; Bu Y
Medicine (Baltimore); 2020 Nov; 99(48):e23339. PubMed ID: 33235099
[TBL] [Abstract][Full Text] [Related]
19. High Levels of Gamma-Glutamyl Transferase and Indocyanine Green Retention Rate at 15 min as Preoperative Predictors of Tumor Recurrence in Patients With Hepatocellular Carcinoma.
Song P; Inagaki Y; Wang Z; Hasegawa K; Sakamoto Y; Arita J; Tang W; Kokudo N
Medicine (Baltimore); 2015 May; 94(21):e810. PubMed ID: 26020384
[TBL] [Abstract][Full Text] [Related]
20. Combined Hangzhou criteria with neutrophil-lymphocyte ratio is superior to other criteria in selecting liver transplantation candidates with HBV-related hepatocellular carcinoma.
Xiao GQ; Yang JY; Yan LN
Hepatobiliary Pancreat Dis Int; 2015 Dec; 14(6):588-95. PubMed ID: 26663006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
